Your browser doesn't support javascript.
loading
Role of 25-hydroxyvitamin D in irritable bowel syndrome patients.
Alvi, Haris; Ali, Gohar; Iqbal, Sadia; Ahsan, Muhammad Nadeem; Siddiqui, Muhammad Ali; Kirmani, Tooba Ahmed; Irshad, Ghazala; Baktashi, Haisum; Asghar, Muhammad Sohaib.
Afiliación
  • Alvi H; Department of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan.
  • Ali G; Department of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan.
  • Iqbal S; Department of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan.
  • Ahsan MN; Department of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan.
  • Avinash; Liaquat National Hospital and Medical College, Karachi, Pakistan.
  • Siddiqui MA; Liaquat National Hospital and Medical College, Karachi, Pakistan.
  • Kirmani TA; Department of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan.
  • Irshad G; Department of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan.
  • Baktashi H; Liaquat National Hospital and Medical College, Karachi, Pakistan.
  • Asghar MS; Department of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan.
J Family Med Prim Care ; 11(12): 7975-7978, 2022 Dec.
Article en En | MEDLINE | ID: mdl-36994062
We conducted this study on patients diagnosed with irritable bowel syndrome without identifiable stressors and replaced them with vitamin D supplements for 3 months. Almost 97 cases have repeated the vitamin D status that appeared to be sufficient, while 14 patients were missing data for follow-up. The advised option was intramuscular injection replacement but 34 out of 97 were taken oral route for replacement of Vitamin D and incidental finding is noted that serum vitamin D levels rise less in the oral group than in the intramuscular group. Mean age of our subjects was 35.97 ± 9.89 years, comprising 54% males (n = 60) and 46% females (n = 51). In the outcomes of our study, 56.7% of individuals showed complete relief from IBS symptoms after vitamin D replacement, while 36.1% reported considerable improvement. Another 6.2% had exhibited moderate relief with about 14 individuals lost to follow-up.
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: J Family Med Prim Care Año: 2022 Tipo del documento: Article País de afiliación: Pakistán Pais de publicación: India
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: J Family Med Prim Care Año: 2022 Tipo del documento: Article País de afiliación: Pakistán Pais de publicación: India